← Leaderboards
Jerrie Selga Refuerzo
Nano3d Biosciences, Inc.
$279,218
Attributed
$621,925
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $238.4K · FY2014–16$250K$187.5K$125K$62.5K$0
'14
'15
'16
Funding mix
By agency
NIH$621,925 · 2
By mechanism
R21$431,457 · 1
R41$190,468 · 1
Top collaborators
- Biana Godin3 shared
- Glauco Ranna Souza1 shared
Most similar at Nano3d Biosciences, Inc.
Same institution · by research overlap
- Biana Godin$753,648
- Glauco Ranna Souza$138,489
Others in their field
Top investigators on “Surface”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$207,726,216
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$118,664,913
Research focus
SurfacePharmaceutical PreparationsMyometrialPremature LaborUterine ContractilityTissuesAreaLeadOrganPremature BirthTocolytic AgentsToxic EffectUterine ContractionBiologicalBirthBlood CirculationIndomethacinIn VivoBaseMyometriumAffectBiodistributionFigs - DietaryFetal Blood
Grant awards (3)
Development of Nanovectors to Prevent Placental Passage of a Tocolytic Agent$193,054
R21 · FY2016 · HD · contact PI
Development of Nanovectors to Prevent Placental Passage of a Tocolytic Agent$238,403
R21 · FY2015 · HD · contact PI
A novel 3D cell culture human uterine contractility assay for high-throughput scr$190,468
R41 · FY2014 · HD